Table 2. Association statistics between relative Gal-3 and relative PSA levels.
Group | rho | P-value | Slope | 90% CI | P-value |
---|---|---|---|---|---|
All men | 0.446 | < 0.0001* | 0.448 | (0.302, 0.593) | < 0.0001* |
Healthy controls | 0.347 | 0.1451 | 0.347 | (0.031, 0.664) | 0.0734 |
Newly diagnosed | 0.616 | 0.0050* | 0.438 | (0.244, 0.633) | 0.0011* |
No recurrence | 0.484 | 0.0360* | 0.470 | (0.156, 0.785) | 0.0187* |
Rising PSA | 0.202 | 0.4075 | 0.162 | (-0.048, 0.372) | 0.1967 |
Metastasis | 0.395 | 0.0944 | 0.368 | (-0.074, 0.810) | 0.1661 |
Gal-3 and PSA concentrations were divided by their respective autoantibody levels, and the values were referred to as relative Gal-3 and relative PSA. The table shows Spearman rank correlation coefficients (rho values) and their P-values (left) between relative Gal-3 and relative PSA level for each clinical group. The fitted slope, its 90% confidence interval (CI), and P-value are also shown for the linear regression model of relative PSA and relative Gal-3 (right). A P-value of less than 0.05 was considered statistically significant and shown with asterisks (*).